{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:13:53Z","timestamp":1788556433194,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016508","name":"Genetix Biotherapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2026.201702","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:55:19Z","timestamp":1771401319000},"page":"201702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["CSF and plasma neuro-biomarker dynamics after gene therapy for cerebral adrenoleukodystrophy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8919","authenticated-orcid":false,"given":"T.C.","family":"Lund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.O.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Loes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Nascene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201702_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11910-014-0486-0","article-title":"X-linked adrenoleukodystrophy: pathogenesis and treatment","volume":"14","author":"Engelen","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.omta.2026.201702_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omta.2026.201702_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201702_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.410160603","article-title":"Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy","volume":"16","author":"Moser","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omta.2026.201702_bib5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1750-3639.2010.00394.x","article-title":"Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy","volume":"20","author":"Cartier","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.omta.2026.201702_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpneuro0421","article-title":"X-linked adrenoleukodystrophy","volume":"3","author":"Moser","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.omta.2026.201702_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201702_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/WNL.34.11.1410","article-title":"Bone marrow transplant in adrenoleukodystrophy","volume":"34","author":"Moser","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201702_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201702_bib10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201702_bib11","article-title":"Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201702_bib12","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1038\/s41598-022-11552-7","article-title":"Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy","volume":"12","author":"Taghizadeh","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201702_bib13","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.bbmt.2020.06.019","article-title":"Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy","volume":"26","author":"Lund","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201702_bib14","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1038\/s41598-019-44140-3","article-title":"Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy","volume":"9","author":"Orchard","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201702_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3174\/ajnr.A4500","article-title":"Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients","volume":"37","author":"Miller","year":"2016","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omta.2026.201702_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050430","article-title":"Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction","volume":"7","author":"Thibert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201702_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032218","article-title":"Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity","volume":"7","author":"Lund","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201702_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1742-2094-8-144","article-title":"Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy","volume":"8","author":"Orchard","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.omta.2026.201702_bib19","article-title":"Prognostic Value of Serum\/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality","author":"Masvekar","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.omta.2026.201702_bib20","article-title":"Plasma Neurofilament Light Chain as a Predictive Biomarker for Post-stroke Cognitive Impairment: A Prospective Cohort Study","volume":"13","author":"Wang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.omta.2026.201702_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061537","article-title":"Neurofilament Light Chain (NfL) in Blood-A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke","volume":"10","author":"Pekny","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201702_bib22","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.4103\/1673-5374.308072","article-title":"Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives","volume":"16","author":"Falzone","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.omta.2026.201702_bib23","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1212\/WNL.0000000000009983","article-title":"Neurofilament light as a biomarker in traumatic brain injury","volume":"95","author":"Shahim","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201702_bib24","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.omta.2026.201702_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.omta.2026.201702_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/620581","article-title":"Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases","volume":"2015","author":"Brkic","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.omta.2026.201702_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","article-title":"Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation","volume":"1347","author":"Scholz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omta.2026.201702_bib28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/acn3.51188","article-title":"Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy","volume":"7","author":"van Ballegoij","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.omta.2026.201702_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2009.03.010","article-title":"Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS\/MS) method","volume":"97","author":"Hubbard","year":"2009","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omta.2026.201702_bib30","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fcell.2020.00690","article-title":"Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders","volume":"8","author":"Jaspers","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omta.2026.201702_bib31","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omta.2026.201702_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s43856-025-00915-6","article-title":"Neurofilament light chain as a biomarker to indicate early activation of cerebral disease in boys with adrenoleukodystrophy","volume":"5","author":"Lund","year":"2025","journal-title":"Commun. Med."},{"key":"10.1016\/j.omta.2026.201702_bib33","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMoa2400442","article-title":"Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Eichler","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201702_bib34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/bloodadvances.2021005294","article-title":"Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy","volume":"6","author":"Chiesa","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.omta.2026.201702_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105442","article-title":"Microglia Regulate Blood-Brain Barrier Integrity via MiR-126a-5p\/MMP9 Axis during Inflammatory Demyelination","volume":"9","author":"Yu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.omta.2026.201702_bib36","article-title":"An In Vitro Model of the Blood-Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis","volume":"13","author":"Schofield","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.omta.2026.201702_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood-2018-11-887240","article-title":"Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy","volume":"133","author":"Orchard","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201702_bib38","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1182\/bloodadvances.2023010923","article-title":"Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning","volume":"7","author":"Nolan","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.omta.2026.201702_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:30:53Z","timestamp":1788553853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X26000376"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201702","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF and plasma neuro-biomarker dynamics after gene therapy for cerebral adrenoleukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201702"}}